СYTOKINES IN OROPHARYNGEAL LAVAGES FROM THE PATIENTS WITH CHRONIC ADENOIDITIS IN THE COURSE OF LOCAL MONOTHERAPY WITH IMUNOPHAN
Abstract. Since decades, the aspects of chronic adenoiditis draw attention of specialists in ORL. From different data, prevalence of chronic adenoiditis is 20 to 56 per cent among children with diseases of upper respiratory ways. Chronic adenoiditis is relatively resistant to conventional therapy, a...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | RU |
| Publicado: |
SPb RAACI
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cba6992f91764c50abbaa96df377518d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Abstract. Since decades, the aspects of chronic adenoiditis draw attention of specialists in ORL. From different data, prevalence of chronic adenoiditis is 20 to 56 per cent among children with diseases of upper respiratory ways. Chronic adenoiditis is relatively resistant to conventional therapy, and irreversible clinical course is revealed in more severe cases. The studies performed have shown that the patients with chronic adenoiditis exhibit signs of local immune deficiency that manifested into decreased local secretion of IL-4, IL-10 and GM-CSF, thus being considered as an indication for local immunocorrection procedures. To this purpose, we used Imunophan as a spray for intranasal application. Dynamics of clinical symptoms and local immune parameters showed that the efficiency of Imunophan treatment was dependent of both initial clinical features of the disorder, and on cytokine levels in oropharyngeal lavages. Therapeutic effect of Imunophan was more expressed in the patients with initial predomination of Th1 immune response and cell-type immune reactions in the area of inflammation. A set of certain clinical and laboratory data, i.e., absence of enlarged pharyngeal glands, predominance of local Th1 type response and cellular type of immune response may be used for monitoring before administration of local immunotherapy with Imunophan in the patients with chronic adenoiditis. (Med. Immunol., 2008, vol. 10, N 2-3, pp 261-268). |
|---|